3rd Quarter - Report
DLA PIPER LLP (US) for XEROX HOLDINGS CORPORATION
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Ensuring full patient access to drug label and package insert information. H.R. 5133, Patients Right to Know Their Medication Act of 2025.
Foreign entity interest: Apex Swiss Holdings Sarl and the other entities listed on Form LD-1, interests are limited to those of direct and indirect parent companies and owners.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMIE ALEXEI GREGORIAN | — |
| KARINA LYNCH | — |
| MAREN MCBRIDE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.